1. Nutrients. 2018 Sep 17;10(9):1314. doi: 10.3390/nu10091314.

Dissociation of Fatty Liver and Insulin Resistance in I148M PNPLA3 Carriers: 
Differences in Diacylglycerol (DAG) FA18:1 Lipid Species as a Possible 
Explanation.

Franko A(1)(2)(3), Merkel D(4), Kovarova M(5)(6)(7), Hoene M(8), Jaghutriz 
BA(9)(10)(11), Heni M(12)(13)(14), Königsrainer A(15), Papan C(16), Lehr 
S(17)(18), Häring HU(19)(20)(21), Peter A(22)(23)(24).

Author information:
(1)Department of Internal Medicine IV, Division of Endocrinology, Diabetology, 
Angiology, Nephrology and Clinical Chemistry, University Hospital Tübingen, 
72076 Tübingen, Germany. andras.franko@med.uni-tuebingen.de.
(2)Institute for Diabetes Research and Metabolic Diseases of the Helmholtz 
Center Munich, University of Tübingen, 72076 Tübingen, Germany. 
andras.franko@med.uni-tuebingen.de.
(3)German Center for Diabetes Research (DZD e.V.), 85764 Neuherberg, Germany. 
andras.franko@med.uni-tuebingen.de.
(4)Sciex Germany GmbH, 64293 Darmstadt, Germany. dietrich.merkel@sciex.com.
(5)Department of Internal Medicine IV, Division of Endocrinology, Diabetology, 
Angiology, Nephrology and Clinical Chemistry, University Hospital Tübingen, 
72076 Tübingen, Germany. kovarova-marketa@seznam.cz.
(6)Institute for Diabetes Research and Metabolic Diseases of the Helmholtz 
Center Munich, University of Tübingen, 72076 Tübingen, Germany. 
kovarova-marketa@seznam.cz.
(7)German Center for Diabetes Research (DZD e.V.), 85764 Neuherberg, Germany. 
kovarova-marketa@seznam.cz.
(8)Department of Internal Medicine IV, Division of Endocrinology, Diabetology, 
Angiology, Nephrology and Clinical Chemistry, University Hospital Tübingen, 
72076 Tübingen, Germany. miriam.hoene@med.uni-tuebingen.de.
(9)Department of Internal Medicine IV, Division of Endocrinology, Diabetology, 
Angiology, Nephrology and Clinical Chemistry, University Hospital Tübingen, 
72076 Tübingen, Germany. benjamin.jaghutriz@med.uni-tuebingen.de.
(10)Institute for Diabetes Research and Metabolic Diseases of the Helmholtz 
Center Munich, University of Tübingen, 72076 Tübingen, Germany. 
benjamin.jaghutriz@med.uni-tuebingen.de.
(11)German Center for Diabetes Research (DZD e.V.), 85764 Neuherberg, Germany. 
benjamin.jaghutriz@med.uni-tuebingen.de.
(12)Department of Internal Medicine IV, Division of Endocrinology, Diabetology, 
Angiology, Nephrology and Clinical Chemistry, University Hospital Tübingen, 
72076 Tübingen, Germany. martin.heni@med.uni-tuebingen.de.
(13)Institute for Diabetes Research and Metabolic Diseases of the Helmholtz 
Center Munich, University of Tübingen, 72076 Tübingen, Germany. 
martin.heni@med.uni-tuebingen.de.
(14)German Center for Diabetes Research (DZD e.V.), 85764 Neuherberg, Germany. 
martin.heni@med.uni-tuebingen.de.
(15)Department of General, Visceral and Transplant Surgery, University Hospital 
Tübingen, 72076 Tübingen, Germany. alfred.koenigsrainer@med.uni-tuebingen.de.
(16)Sciex Germany GmbH, 64293 Darmstadt, Germany. cyrus.papan@sciex.com.
(17)German Center for Diabetes Research (DZD e.V.), 85764 Neuherberg, Germany. 
stefan.lehr@ddz.uni-duesseldorf.de.
(18)Institute for Clinical Biochemistry and Pathobiochemistry of DDZ, University 
of Düsseldorf, 40225 Düsseldorf, Germany. stefan.lehr@ddz.uni-duesseldorf.de.
(19)Department of Internal Medicine IV, Division of Endocrinology, Diabetology, 
Angiology, Nephrology and Clinical Chemistry, University Hospital Tübingen, 
72076 Tübingen, Germany. hans-ulrich.haering@med.uni-tuebingen.de.
(20)Institute for Diabetes Research and Metabolic Diseases of the Helmholtz 
Center Munich, University of Tübingen, 72076 Tübingen, Germany. 
hans-ulrich.haering@med.uni-tuebingen.de.
(21)German Center for Diabetes Research (DZD e.V.), 85764 Neuherberg, Germany. 
hans-ulrich.haering@med.uni-tuebingen.de.
(22)Department of Internal Medicine IV, Division of Endocrinology, Diabetology, 
Angiology, Nephrology and Clinical Chemistry, University Hospital Tübingen, 
72076 Tübingen, Germany. andreas.peter@med.uni-tuebingen.de.
(23)Institute for Diabetes Research and Metabolic Diseases of the Helmholtz 
Center Munich, University of Tübingen, 72076 Tübingen, Germany. 
andreas.peter@med.uni-tuebingen.de.
(24)German Center for Diabetes Research (DZD e.V.), 85764 Neuherberg, Germany. 
andreas.peter@med.uni-tuebingen.de.

Fatty liver is tightly associated with insulin resistance and the development of 
type 2 diabetes. I148M variant in patatin-like phospholipase domain-containing 
protein 3 (PNPLA3) gene is associated with high liver fat but normal insulin 
sensitivity. The underlying mechanism of the disassociation between high liver 
fat but normal insulin sensitivity remains obscure. We investigated the effect 
of I148M variant on hepatic lipidome of subjects with or without fatty liver, 
using the Lipidyzer method. Liver samples of four groups of subjects consisting 
of normal liver fat with wild-type PNPLA3 allele (group 1); normal liver fat 
with variant PNPLA3 allele (group 2); high liver fat with wild-type PNPLA3 
allele (group 3); high liver fat with variant PNPLA3 allele (group 4); were 
analyzed. When high liver fat to normal liver fat groups were compared, 
wild-type carriers (group 3 vs. group 1) showed similar lipid changes compared 
to I148M PNPLA3 carriers (group 4 vs. group 2). On the other hand, in wild-type 
carriers, increased liver fat significantly elevated the proportion of specific 
DAGs (diacylglycerols), mostly DAG (FA18:1) which, however, remained unchanged 
in I148M PNPLA3 carriers. Since DAG (FA18:1) has been implicated in hepatic 
insulin resistance, the unaltered proportion of DAG (FA18:1) in I148M PNPLA3 
carriers with fatty liver may explain the normal insulin sensitivity in these 
subjects.

DOI: 10.3390/nu10091314
PMCID: PMC6164484
PMID: 30227635 [Indexed for MEDLINE]

Conflict of interest statement: The authors declare no conflict of interest. 
D.M. and C.P. are employed by Sciex Germany GmbH, Darmstadt, Germany, which, 
however, had no influence in the design of the study; analyses, or 
interpretation of data; in the writing of the manuscript; or in the decision to 
publish the results.